Proper formation of the pulmonary microvasculature is essential for normal lung development and gas exchange. Lung microvascular development may be disrupted by chronic injury of developing lungs in clinical diseases such as BPD (bronchopulmonary dysplasia). We examined microvascular development, angiogenic growth factors and endothelial cell receptors in a fetal baboon model of chronic lung disease (CLD). In the last third of gestation, the endothelial cell marker PECAM-1 increased 7.5 fold and capillaries immunostained for PECAM-1 changed from a central location in airspace septa to a subepithelial location. In premature animals delivered at 67% of term and supported with oxygen and ventilation for 14 days, PECAM-1 protein and capillary density did not increase, suggesting failure to expand the capillary network. The capillaries of the CLD animals were dysmorphic and not subepithelial. The angiogenic growth factor VEGF and its receptor Flt-1 were significantly decreased in CLD. Angiopoietin-1, another angiogenic growth factor, and its receptor TIE-2 were not significantly changed. These data suggest that CLD impairs lung microvascular development and that a possible mechanism is disruption of VEGF and Flt-1 expression.
INTRODUCTION
Premature infants treated with ventilation and supplemental oxygen frequently develop bronchopulmonary dysplasia (BPD), a chronic lung disease that has significant mortality and morbidity. The combination of immature lungs, oxidant injury, volutrauma and chronic inflammation are probably important etiologic factors in BPD. The pathology of BPD, including poor alveolarization and a dysmorphic microvasculature, suggest an arrest in lung development (9, 22) . Proper formation of alveolar capillaries, a key step in lung development, is required for efficient gas exchange. Alveolar capillary development begins in early fetal lung and continues through the alveolar stage (7, 37) . The complex process of endothelial differentiation and organization into the alveolar microvasculature might be disrupted after premature birth and injury from supplemental oxygen and ventilation. In an autopsy study of human premature newborns dying with BPD, we found an abnormal alveolar capillary network and decreased expression of an endothelial cell marker (5) .
The lung endothelial cell population increases continuously during gestation (37) . Vessel formation occurs by two processes: vasculogenesis, the development of vessels from endothelial cells that differentiate from mesenchymal precursors; and angiogenesis, the sprouting of new vessels from the pre-existing vasculature. Both processes occur in the developing lung (14, 38) . During lung differentiation, the distal microvasculature, which probably forms by vasculogenesis, transforms from loosely organized capillaries imbedded in the mesenchyme to an extensive network of sub-epithelial alveolar capillaries. In the cannalicular stage (18-26 weeks gestation in the human), the capillaries are located centrally in thickened distal airspace septa (7) . As the septa become thin, the capillaries become closely aligned with the distal epithelium, which is differentiating into type I and type II cells. 4 The regulation of pulmonary microvascular development is not known, but epithelial and mesenchymal interactions may be essential (20) . The processes necessary for vascular development, including endothelial cell differentiation, migration, interaction with the basement membrane, formation of cell-cell junctions and attraction of supporting pericytes, can be regulated by several growth factors. Of particular interest are the Vascular Endothelial Growth Factor family (VEGF A-D) and the Angiopoietin family (Ang 1-4). Because their receptors are largely restricted to endothelial cells, the actions of these factors are mainly endothelial cell specific (46) . VEGF (also known as VEGF-A) is mitogenic for endothelial cells, induces capillary permeability and regulates endothelial cell migration and tube formation. VEGF may also be an endothelial cell survival factor (2) . Loss of a single VEGF allele is embryo-lethal, underscoring its critical role in vascular development (8) . VEGF has several isoforms that are produced by alternative splicing of the primary mRNA. The splice variants are differentially expressed in lung development and injury (43) . The VEGF receptors Flt-1 (VEGFR-1) and Flk-1 (VEGFR-2) have different functions: Flt-1 may mediate vascular organization and Flk-1 mediates endothelial differentiation and proliferation (17, 39) . VEGF is expressed by distal airspace epithelial cells in fetal and postnatal lung (4, 47) . Hypoxia, growth factors and cell differentiation, which are key in lung development and injury, regulate VEGF expression (4, 6, 28) .
Angiopoietin-1 (Ang-1) ligation to its receptor TIE-2 mediates vascular remodeling and endothelial interactions with supporting cells (41) . A related endothelial receptor, TIE-1, regulates endothelial cell integrity and is essential for vessel network formation, particularly in the later stages of embryonic development (36) . The ligand for TIE-1 is not known. The VEGF and Ang-1 families work in concert during vessel formation (3).
Most studies of vascular changes in chronic lung disease of infancy have relied on autopsy samples (9) , which are limited by the decreasing mortality from BPD and the inherent 5 variability of tissue from human patients. Most of these studies did not focus on the alveolar microvasculature. Studies of postnatal animals treated with hyperoxia or ventilation cannot address the effects of these injuries at critical stages of lung development. Premature baboons delivered at 140 days gestation (75% of term) and treated with 100% oxygen and ventilation for 10 days had decreased endothelial cells in hyper-expanded lung (10), consistent with the toxic effects of oxygen on pulmonary endothelial cells (13). Using baboons that were delivered at 125 days (67% of term) and treated with surfactant, appropriate oxygen and ventilation for 1-2 months, Coalson et al found alveolar hypoplasia, decreased vascularization and dysmorphic alveolar capillaries compared to term animals (11) .
In previous work, we found that acute hyperoxic injury decreased lung VEGF expression (25) . We hypothesized that injury to premature lungs would lead to disrupted vascular development, possibly by altering the normal genetic program for angiogenic factor expression.
The present work reports the temporal and spatial expression of an endothelial cell marker (PECAM-1), VEGF and Ang-1, and their receptors in normal fetal baboon lung and in 125 day gestation animals after 6 days and 14 days of oxygen and ventilation. These animals had decreased PECAM-1 expression, decreased capillary density and abnormal development of alveolar capillaries, compared to gestational controls. Expression of VEGF, its receptor Flt-1, and TIE-1 were decreased in injured lung. Flk-1, Ang-1 and Tie-2 were unchanged. These data show that development of chronic lung disease rapidly results in abnormal alveolar capillaries, which may be due to disruption of the normal genetic program for angiogenic factor/receptor expression.
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METHODS
Animals and treatment protocols:
Frozen baboon lung tissue and slides from paraffinimbedded tissue were obtained from the Southwest Foundation for Biomedical Research (San Antonio, TX). Detailed protocols for baboon pregnancy, delivery and postnatal management have been described (11) . All animal protocols conformed with American Association for Accreditation of Animal Care (AAALAC) guidelines. Briefly, timed gestations were confirmed by serial ultrasounds. Baboons were delivered by hysterotomy at 125 days, 140 days, 160 days and 175 days gestation (term is 185 days). Animals killed immediately after delivery are gestational controls. Some animals were killed at 1-3 days after term delivery. Study animals were delivered at 125 days gestation (67% of term), intubated and immediately treated with exogenous surfactant. Infant animals were treated with ventilation (pressure-limited, timecycled) to maintain tidal volumes of 4-6 ml/kg and PaCO 2 between 45 and 55 mm Hg.
Supplemental oxygen was given to maintain PaO 2 55-70 mm Hg. PEEP was adjusted to maintain normal lung volumes. Nutritional and fluid support were delivered to maintain urine output and caloric intake using intravenous protein and lipid solutions. All animals were treated with antibiotics. Some animals were killed after 6 days of support (125d 6dPRN) and others were killed after 14 days (125d 14d PRN). The 125d 14dPRN animals were compared to 140 day gestational controls to determine the effects of premature delivery and postnatal treatment on the progress of normal in utero lung development.
Tissue Preparation: At necropsy the lungs were prepared as described by Coalson et al (11) .
Briefly, lungs were inflation-fixed with 4% paraformaldehyde at 20 cm H 2 O pressure for 24 hrs.
Lung tissue blocks were dehydrated, imbedded in paraffin and 4µ sections cut. Other lung tissue samples were immediately frozen in liquid nitrogen. Western Immunoblot: As described previously (34) , approximately 100mg of frozen lung tissue was homogenized in 50mM Tris-HCl, pH7.4, 150mM NaCL, 2mM EDTA, 25mM sodium flouride, α-glycerolphosphate, 0.1mM sodium vanidate, 1mM phenylmethylsufonylflouride (PMSF), 0.2% TritonX-100, 0.3% Igepal CA-630, 10ug/ml leupeptin, 10ug/ml pepstatin A, 10ug/ml aprotinin,#A6279 (Sigma). Proteins (10ug) in Laemmli buffer were separated on polyacrylamide-SDS gels and transferred to polyvinylidene difluoride (PVDF) membrane. resolved on a 6% acrylamide/urea gel (GIBCO BRL), using radiolabeled probe (1,000-2,000 cpm) as size markers. The gels were dried and analyzed by phosphorimaging (Molecular Dynamics, Sunnyvale, CA). Abundance of each mRNA was expressed relative to mRNA for L32, a ribosomal protein.
Northern Hybridization: Analysis of Flk-1 (VEGFR-2) mRNA was conducted as described previously (4) . The cDNA, which was made by RT-PCR of human RNA, is 591 bp and corresponds to bases 2837-3427 of the coding region. The northern hybridization was quantified by prosphorimaging using the ribosomal 18S band for normalization.
Immunohistochemistry: For PECAM-1 immunohistochemistry, slides were rinsed in xylenes and ethanol and then rehydrated in an ethanol series. Antigen retrieval was performed in 100 mM Tris-HCl, pH 10. Slides were heated in a microwave for 4min and then on 50% power for 10 min. The slides were blocked in TBS (Tris HCl, 150mM NaCl, pH 7.5)/ 2% horse serum. Primary Amplified products were separated on highly denaturing polyacrylamide gels and quantified by phosphorimaging and image analysis. To account for differences in signal intensity due to the differences in splice variant sizes, the data were expressed as molar ratios.
RESULTS
Lung PECAM-1 protein and mRNA increase during gestation and are decreased in CLD:
PECAM-1 is a marker for endothelial cells. Lung PECAM-1 protein increased 7.5 fold between 125 days gestation and 1-3 days postnatal life as demonstrated by western immunoblot (Fig 1 A and B), indicating a substantial expansion of the endothelial cell population. Expression of PECAM-1 mRNA also increased steadily during lung development (Fig 1C) . Animals delivered on day 125 of gestation and supported for 6 days with appropriate supplemental oxygen and ventilation (125d 6dPRN) had no increase in PECAM-1 protein or mRNA (Fig 1D and E) . By 14 days of supplemental oxygen and ventilation (125d 14dPRN), PECAM-1 protein had not changed from125 day gestation and was reduced by nearly 70% compared to the 140 day gestational controls (Fig 1D) . PECAM-1 mRNA was also significantly reduced in the 125d Abnormal immunostaining for PECAM-1 in CLD animals: Immunohistochemistry for lung PECAM-1 in 125 day gestational controls showed isolated capillaries imbedded in the thick septa of the distal potential airspaces (Fig 2A) . The septa frequently had several capillaries, but few capillaries had a subepithelial location and inter-capillary connections were sparse. By 140 days gestation, more extensive capillary development was noted in thinner septa (Fig 2B) .
Rather than isolated capillaries, long segments of capillaries were identified, suggesting an interconnecting network. Many capillary segments were immediately subepithelial (Fig 2B, arrows). By day 160 (Fig 2C) , the septa were very thin and the endothelium appeared to constitute an increasing proportion of septal cells. The 175day gestational controls had an extensive capillary network that extended into the secondary septa (Fig 2D) .
The 125d 6dPRN animals ( Fig 2E) had thick septa and endothelial cells of isolated capillaries imbedded centrally in the septa. By 14 days of appropriate oxygen and ventilation (Fig 2F) , the distal airspaces were large and the septa remained thickened and hypercellular.
Isolated capillaries were centrally located with few capillaries found in subepithelial locations.
Compare to the 140 day gestational controls, the 125d 14dPRN animals had decreased PECAM-1 staining and lacked an extensive capillary network, similar to the 125 day gestational controls, suggesting disruption of normal microvascular development.
Decreased endothelial cell area in CLD lung:
To quantify capillary density, we used computer-assisted measurement of the PECAM-1 immunostained area compared to total parenchymal cell area, using differential interference contrast (Fig 3) . The tissue sections analyzed contained mainly the alveolar parenchyma and excluded any large airways or blood vessels. Between 125 days and 140 days gestation, the area of PECAM-1 immunostaining increased from 31 +/-2% to 39 +/-2% (mean +/-SEM) of total parenchymal area (p<.05). In the CLD animals, however, the relative PECAM-1 immunostained area did not increase above the value at 125 days. The 125d 14dPRN animals had a significantly decreased proportion of PECAM-1 immunostained area compared to the 140 day gestational controls (27 +/-1% vs 39 +/-2%; p<.001). These data suggest that the relative capillary density did not increase in the CLD animals.
Lung VEGF expression increases during gestation but is disrupted with CLD: To evaluate potential mechanisms of normal and abnormal capillary development, we investigated expression of VEGF, Ang-1 and their receptors. In situ hybridization for VEGF mRNA during 13 lung development (Fig 4A-D) showed that the 125 day gestational controls had VEGF message scattered in the thick inter-airspace septa. A high concentration of VEGF mRNA was noted in occasional cells on the surface of the septa. At 140 days gestation (Fig 4B) , VEGF message was concentrated in isolated cells of the septal epithelium (arrow), although the interior septal cells continued to have some message. By 160 days gestation (Fig 4C) , the message was almost exclusively in isolated septal epithelial cells. As the septa thinned in more mature animals ( Fig 4D) VEGF mRNA remained in isolated septal epithelial cells, which resembled cuboidal type II cells on higher power (not shown). Little VEGF mRNA was noted in airway epithelial cells. The relative abundance of total lung VEGF mRNA increased during development and remained relatively high in the adult (Fig 4E) . The proportions of the alternatively spliced variants of VEGF mRNA changed during lung development, with VEGF 189
increasing from 14% at 125 days gestation to 30% at 3 days postnatal life (p<.05; Fig 4F) .
In the 125 day gestation animals that received appropriate oxygen and ventilation for 6 days, VEGF mRNA was scattered in the inter-airspace septa (Fig 5A) . By 14 days of oxygen and ventilation (Fig 5B) , VEGF message was decreased in many areas of lung compared to the 140 day gestational controls. Fewer epithelial cells with intense VEGF signal were noted in these areas. However, some areas of lung had relatively well-preserved VEGF expression, particularly where airspace septa were not thick (not shown), suggesting heterogeneity of the injury. Total lung VEGF mRNA was significantly decreased in the 125d 14dPRN animals compared to the 140 day gestational controls (Fig 5C) . There were no changes in the relative proportions of the mRNA splice variants (data not shown).
Decreased VEGF immunohistochemistry in CLD:
Immunostaining for VEGF during lung development followed a pattern similar to the in situ hybridizations (Fig 6A-D) . The 125 day gestation animals had VEGF protein detected in the distal potential airspace septa. By 175 days gestation, the protein was localized in cuboidal epithelial cells, likely type II cells, in the septa.
Little VEGF protein was detected in airway cells (not shown). The 125 6dPRN animals had VEGF immunostaining in the septa (Fig 6E) . However, the 125d 14dPRN animals had substantially decreased VEGF immunostaining, particular in areas where the distal airspace septa were thickened (Fig 6F) . Together, these data suggest that 125 day gestation lungs treated with appropriate oxygen and ventilation have decreased expression of VEGF mRNA and protein compared to the 140 day gestational controls.
Ang-1 and its receptor TIE-2 are not altered in CLD:
In situ hybridization for Ang-1 in the 125 day and 140 day gestation animals showed mRNA scattered among cells in the potential distal airspace septa (Fig 7A and B) . Unlike VEGF, which was expressed in epithelial cells, Ang-1 message was not concentrated in any particular cell type. Little Ang-1 message was detected in airway cells or smooth muscle. A similar pattern was observed in the 125d 6dPRN and 125d 14dPRN animals: Ang-1 message was detected mainly in the septal mesenchymal cells (Fig 7C   and D) . RPA for Ang-1 and TIE-2 showed that the messages increased in whole lung during development and did not change during the course of exposure to appropriate oxygen and ventilation (Fig 8A -D) . (Representative lanes for the RPAs are shown in Figure 10 .)
The endothelial cell receptors Flt-1 and TIE-1 mRNAs decrease in CLD: Flt-1 (VEGFR-1) mRNA increased during fetal lung development, with a peak at 175 days gestation, but declined in postnatal lung (Fig 9A) . Flk-1 (VEGFR-2) mRNA increased 3.7 fold between 125 and 160 days gestation (Fig 9B) . TIE-1 mRNA, an orphan tyrosine kinase receptor that mediates vascular network formation in latter stages of development, increased during lung development, had maximal message abundance towards the end of gestation, but declined in the postnatal lung (Fig 9C) . During the course of 6 days or 14 days of appropriate oxygen and ventilation, messages for both Flt-1 and TIE-1 did not increase from the 125 day gestation values (Fig 9D   15 and F). The 125d 14dPRN animals had significantly less mRNA for these two receptors than the 140 day gestational controls. There was no effect of injury on Flk-1 expression (Fig 8E) . We found that the endothelial marker, PECAM-1, increased more than 7 fold from 125 days gestation to term, consistent with expansion of the pulmonary vasculature. As noted in this study in primates and by others in rodents (7), the morphology of the distal airspace capillaries changed from isolated capillaries imbedded in thick septa at 125 days gestation to a more complex capillary network that was largely subepithelial at 140 days gestation. This time is equivalent to ~24-26 weeks gestation in the human. Our finding of increased lung VEGF and Ang-1 expression during gestation and the localization of VEGF to the distal airspace epithelium supports the hypothesis that these angiogenic factors contribute to pulmonary microvascular (15), whereas hypoxia, TNF-α and IL-β increase endothelial TIE-2 (44). TIE-1, the orphan receptor that increased in fetal baboon lung but declined postnatally, is induced by VEGF and is essential for latter stages of vascular development (36) .
Few studies have examined microvascular development in immature lung with CLD.
Coalson et al found that 1-2 months of appropriate oxygen and ventilation in 125 day gestation baboons resulted in decreased alveolarization, dysmorphic capillaries and decreased volume density of capillaries (11) . Newborn rats exposed to 100% oxygen for 6 days had decreased capillary number (35) , consistent with the toxic effect of oxygen on endothelial cells. We found decreased PECAM-1 expression in human infants who died with BPD compared to infants with out BPD (5) . In the present study, we found that 125 day gestation baboons treated with appropriate oxygen and ventilation to maintain normal arterial blood gases had a 70% decrease in PECAM-1 protein and a 27% decrease in capillary density compared to 140 day gestation controls. The 125d 14dPRN animals also had dysmorphic capillaries that frequently were in the center of thickened septa rather than subepitheial as in the gestational controls. Together these findings support the hypothesis that CLD results in arrested lung microvascular development. expressed by proliferating cells (25, 26) . Therefore, a change in distal epithelial cell phenotype to proliferative type II cells or to cells with high SP-C might result in decreased VEGF expression. Proof of these speculations is lacking.
We found that expression of the VEGF receptor, Flt-1, and the orphan receptor, TIE-1, were decreased in the 125d 14d PRN animals. A decreased endothelial cell population, as suggested by decreased PECAM-1, might explain these results. However, decreased VEGF in CLD may also contribute to the decline in TIE-1 mRNA because VEGF induces TIE-1 expression (27) . In addition, TIE-1 is induced by hypoxia (27) and may be inhibited by hyperoxia. Both Flt-1 and TIE-1 regulate vascular network formation (17, 36) and loss of these endothelial receptors may result in the disruption of the capillary network in CLD lung. Our finding that Flt-1 but not Flk-1 was decreased in injury suggests independent regulation of these VEGF receptors.
These data have important limitations. The morphometric measurement of capillary density was based on the PECAM-1 immunostained area. Although PECAM-1 is widely used as a marker of endothelial cells, it can be up-or down-regulated in certain conditions (33, 42) .
Threshold gating the computer analysis to count cells that had PECAM-1 immunostaining signal just above background allowed measurement of capillary area that was nearly independent of the absolute amount of PECAM-1. Endothelial cells that were devoid of any PECAM-1 would not be counted, however. We expressed the data as area of PECAM-1 immunostaining per area of parenchymal cells, rather than capillary area per field, to avoid variations resulting from differences in lung inflation. Microvascular morphometrics of the baboons at 1-2 months of age also suggest disrupted alveolar capillary development in CLD (11 
